Kevin Elwood, MD
Retina Specialist · Chicago, ILNPI 1083243802
Payments from drug & device makers
What this record shows
Alcon accounts for 71.3% of it on its own, with 7 other manufacturers making up the rest. That places this record below the midpoint for retina specialist clinicians in IL, where the typical reported total is $2,402.
Across 12 payments — averaging $117.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- AbbVie$150
- Regeneron Healthcare Solutions, Inc.$105
- ANI Pharmaceuticals, Inc.$42
- Apellis Pharmaceuticals, Inc.$32
- Genentech USA, Inc.$32
- plus $45 from 2 others
What the payments were for
- Travel & lodging$74152%
- Food & beverage$67048%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 4 | $1,006 |
| AbbVie | 1 | $150 |
| Regeneron Healthcare Solutions, Inc. | 1 | $105 |
| ANI Pharmaceuticals, Inc. | 2 | $42 |
| Apellis Pharmaceuticals, Inc. | 1 | $32 |
| Genentech USA, Inc. | 1 | $32 |
| Bausch & Lomb Americas Inc. | 1 | $24 |
| Ocular Therapeutix, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,411 in reported general payments places this provider in the 35th percentile of 70 retina specialist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 14 | $97 |
| Latanoprost | 18 | $71 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Chicago
- Rahul KomatiChicago$143K
- Veena RaijiChicago$69K
- Jeffrey ParnellChicago$27K
- Paulpoj ChiranandChicago$17K
- Henry FengChicago$16K
- Shaun IttiaraChicago$9K
- Sarah SyedaChicago$6K
- Saagar PanditChicago$6K
- Daniel BalikovChicago$3K
- Emily ShepherdChicago$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.